Gennaro Di Maro
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.
Journal: Respiratory research
Published: October 12, 2021
Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial.
Journal: The Lancet. Respiratory medicine
Published: June 09, 2021
Long-term immunogenicity and safety of a non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine: 4-year follow-up of a phase 1 multicentre trial.
Journal: Vaccine: X
Published: May 31, 2021
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
Journal: Oncotarget
Published: February 23, 2016
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma.
Journal: Thyroid : official journal of the American Thyroid Association
Published: February 05, 2016
Identification of targets of Twist1 transcription factor in thyroid cancer cells.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 23, 2014
Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
Journal: BMC medical imaging
Published: April 08, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026